External Source:
CFR Task Force Report

“The rise of NCDs in low- and middle-income countries is not merely the byproduct of success — increasing incomes, reductions in infectious diseases such as HIV/AIDS, or greater adoption of unhealthy western lifestyles. Recent improvements in life expectancy explain why more people in developing countries get NCDs. They do not, however, explain why so many people in these countries are developing NCDs so much younger and with such worse outcomes than in wealthier nations […] Premature death and disability from NCDs are increasingly associated with poverty in emerging nations, just as they are in wealthier countries.”

In December 2014, the United States Council on Foreign Relations (CFR) released an independent task force report on NCDs in low- and middle-income countries, geared for an audience of U.S. policymakers and agencies. The report presents a call to action for increased U.S. engagement and leadership in addressing NCDs in low- and middle-income countries worldwide.

In the report, authors discuss current data regarding the burden of NCDs in low-income countries and the status of existing investment to address NCDs in developing countries. The report also outlines the far reaching impact of NCDs on the development and economic sustainability in lower income countries — both in terms of impoverishment, household income, and catastrophic health expenditures of patients and families, as well as nationally in terms of lower workforce productivity, increased health and welfare expenditures, and population health impact. In the final sections of the report, authors make the call to increase U.S. investment in order to reduce preventable and premature death and disability among the poor as a result of NCDs in low-income countries. 

In the report, Task Force members make two primary recommendations for the U.S. government to:

  1. “Undertake a serious examination of its global health programs and consider expanding their mandate” to include NCDs
  2. Convene stakeholders to “develop a well-prioritized and sustainable plan for collective action on NCDs in low- and middle-income countries”

Task Force members include:

  • Mitchell E. Daniels Jr, Chair – Purdue University
  • Thomas E. Donilon, Chair – O’Melveny & Myers
  • Thomas J. Bollyky, Project Director – Council on Foreign Relations
  • David B. Agus – University of Southern California
  • J. Brian Atwood – University of Minnesota, Humphrey School of Public Affairs
  • Samuel R. Berger – Albright Stonebridge Group
  • Karan Bhatia – General Electric (GE)
  • Nancy G. Brinker – Susan G. Komen for the Cure
  • Binta Niambi Brown – Harvard Kennedy School
  • Barbara Byrne – Barclays
  • Jean-Paul Chretien – United States Navy
  • Steve Davis – PATH
  • Ezekiel J. Emanuel – University of Pennsylvania
  • Daniel R. Glickman – Aspen Institute
  • Eric P. Goosby – University of California San Francisco
  • Vanessa Kerry – Seed Global Health
  • Michael J. Klag – Johns Hopkins Bloomberg School of Public Health
  • Risa Lavizzo-Mourey – Robert Wood Johnson Foundation
  • Christopher J.L. Murray – University of Washington
  • Elizabeth G. Nabel – Brigham & Women’s Hospital
  • David Satcher – Morehouse School of Medicine
  • Donna E. Shalala – University of Miami
  • Ira S. Shapiro – Ira Shapiro Global Strategies LLC
  • Tommy G. Thompson – Thompson Family Holdings